Advertisement

Topics

Axovant Release: FDA Grants Fast Track Designation To Axovant's Nelotanserin For Visual Hallucinations In Dementia With Lewy Bodies

20:00 EDT 18 Jun 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Axovant Release: FDA Grants Fast Track Designation To Axovant's Nelotanserin For Visual Hallucinations In Dementia With Lewy Bodies

NEXT ARTICLE

More From BioPortfolio on "Axovant Release: FDA Grants Fast Track Designation To Axovant's Nelotanserin For Visual Hallucinations In Dementia With Lewy Bodies"

Advertisement
Quick Search
Advertisement
Advertisement